Precigen Inc (PGEN)
1.40
-0.02
(-1.41%)
USD |
NASDAQ |
Apr 25, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
Precigen Cash and Short Term Investments (Quarterly): 62.86M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 62.86M |
| September 30, 2023 | 73.76M |
| June 30, 2023 | 88.43M |
| March 31, 2023 | 104.09M |
| December 31, 2022 | 55.95M |
| September 30, 2022 | 71.33M |
| June 30, 2022 | 115.30M |
| March 31, 2022 | 112.14M |
| December 31, 2021 | 108.66M |
| September 30, 2021 | 114.41M |
| June 30, 2021 | 115.11M |
| March 31, 2021 | 105.69M |
| December 31, 2020 | 100.12M |
| September 30, 2020 | 113.10M |
| June 30, 2020 | 133.00M |
| March 31, 2020 | 149.17M |
| December 31, 2019 | 75.05M |
| September 30, 2019 | 106.03M |
| June 30, 2019 | 125.80M |
| March 31, 2019 | 181.82M |
| December 31, 2018 | 216.87M |
| September 30, 2018 | 247.29M |
| June 30, 2018 | 81.13M |
| Date | Value |
|---|---|
| March 31, 2018 | 123.50M |
| December 31, 2017 | 79.67M |
| September 30, 2017 | 108.72M |
| June 30, 2017 | 157.16M |
| March 31, 2017 | 205.23M |
| December 31, 2016 | 237.21M |
| September 30, 2016 | 236.55M |
| June 30, 2016 | 270.75M |
| March 31, 2016 | 260.39M |
| December 31, 2015 | 238.31M |
| September 30, 2015 | 216.30M |
| June 30, 2015 | 166.33M |
| March 31, 2015 | 181.48M |
| December 31, 2014 | 115.96M |
| September 30, 2014 | 123.08M |
| June 30, 2014 | 175.55M |
| March 31, 2014 | 222.81M |
| December 31, 2013 | 177.49M |
| September 30, 2013 | 197.89M |
| June 30, 2013 | 129.92M |
| March 31, 2013 | 60.00M |
| December 31, 2012 | 10.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
55.95M
Minimum
Dec 2022
149.17M
Maximum
Mar 2020
101.58M
Average
106.03M
Median
Sep 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 3.378M |
| HealthEquity Inc | 403.98M |
| Corvus Pharmaceuticals Inc | 27.15M |
| Oragenics Inc | 3.484M |
| MAIA Biotechnology Inc | 7.151M |